PROGNOSYS BIOSCIENCES, INC. — Department of Health and Human Services SBIR Phase I: DESCRIPTION (provided by applicant): The ability to detect rare mutations in a population
PROGNOSYS BIOSCIENCES, INC. — SBIR Phase I award from Department of Health and Human Services.
- Amount
- $233,691
- Agency
- Department of Health and Human Services · National Institutes of Health
- Program / Phase
- SBIR · Phase I
- Solicitation
- PA11-096
- NAICS
- —
- Place of performance
- CA
- Period
- —
Description
DESCRIPTION (provided by applicant): The ability to detect rare mutations in a population of sequences is enabling for a wide range of molecular studies that relate shifts in genotype and phenotype to selective pressures. Although recent technologies haveenabled the analysis of entire genomes for common variation, it is still very challenging to detect rare variants in a sample. This proposal aims to develop a new approach to detect rare genetic variants using next- generation sequencing. Our approach hasimplications for the development of diagnostic and theranostic tests, and the development of novel drugs to treat infectious diseases and cancer. PUBLIC HEALTH RELEVANCE: There are over 200 diseases that are caused by mutations in the mitochondrialgenome. Many of these mutations occur at a low frequency and are difficult to detect. By developing a powerful new method to detect rare variants, we aim to address an important unmet medical need.